1. Home
  2. PLPC vs IMCR Comparison

PLPC vs IMCR Comparison

Compare PLPC & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Preformed Line Products Company

PLPC

Preformed Line Products Company

HOLD

Current Price

$370.33

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$28.84

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLPC
IMCR
Founded
1947
2008
Country
United States
United Kingdom
Employees
N/A
524
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2001
2016

Fundamental Metrics

Financial Performance
Metric
PLPC
IMCR
Price
$370.33
$28.84
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$275.00
$66.33
AVG Volume (30 Days)
96.0K
314.6K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
0.25%
N/A
EPS Growth
N/A
30.39
EPS
2.14
0.25
Revenue
N/A
$249,428,000.00
Revenue This Year
$17.19
$14.57
Revenue Next Year
$7.28
$8.21
P/E Ratio
$176.10
$115.42
Revenue Growth
N/A
43.05
52 Week Low
$138.93
$27.56
52 Week High
$386.90
$40.71

Technical Indicators

Market Signals
Indicator
PLPC
IMCR
Relative Strength Index (RSI) 60.08 46.58
Support Level $193.52 $27.69
Resistance Level $371.80 $31.56
Average True Range (ATR) 16.98 1.09
MACD 1.59 0.06
Stochastic Oscillator 74.27 42.56

Price Performance

Historical Comparison
PLPC
IMCR

About PLPC Preformed Line Products Company

Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. The Company's primary products support, protect, connect, terminate, and secure cables and wires. The Company provides helical solutions, connectors, fiber optic and copper splice closures, solar framing applications, and electric vehicle charging station foundations. The Company's customers include public and private energy utilities and communication companies, cable operators, contractors and subcontractors, distributors, and value-added resellers. Geographically, the company operates in four regions: PLP-USA, the Americas, EMEA, and Asia-Pacific.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: